Health

The Limited Reach of the HIPAA Security Rule

The Limited Reach of the HIPAA Security Rule

A comprehensive legal mandate for health data holders could better protect electronic health information.

HIPAA at 25 Remains a Work in Progress

HIPAA at 25 Remains a Work in Progress

HIPAA has delivered meaningful benefits to consumers but still needs updating to address new and emerging privacy challenges.

Reflecting on 25 Years of HIPAA

Reflecting on 25 Years of HIPAA

To commemorate the 25th anniversary of HIPAA’s passage, leading scholars explore the law’s impact on privacy and health care.

The Wild West of Fertility Clinics

The Wild West of Fertility Clinics

Legal experts argue that the fertility industry is largely unregulated and poses risks to patients.

Regulatory Sandboxes Slowed the Spread of COVID-19

Regulatory Sandboxes Slowed the Spread of COVID-19

Scholar claims that regulatory sandboxes such as emergency use authorizations boost innovation, but at a cost.

Formaldehyde Lurks in Hair Products Despite FDA Warning

Formaldehyde Lurks in Hair Products Despite FDA Warning

FDA warns consumers to protect themselves from a known carcinogen in hair smoothing products.

Regulating Drugs at a Discount

Regulating Drugs at a Discount

Scholars examine the effectiveness of the contentious 340B Drug Pricing Program.

Discriminatory Blood Donation Policies Defy Science

Discriminatory Blood Donation Policies Defy Science

COVID-19 highlights a blood donation deferral policy that clashes with modern science.

Something Fishy About Seafood Inspection

Something Fishy About Seafood Inspection

Government watchdog finds that FDA is not properly inspecting imported seafood.

Barriers to Maternal Health in Rural Areas

Barriers to Maternal Health in Rural Areas

State policies create and exacerbate barriers to access rural health care.

Making Drugs Safe to Kill?

Making Drugs Safe to Kill?

Lawyer proposes a new legal framework for reviewing FDA’s refusal to regulate lethal injection drugs.

Regulatory Control of Potentially Addictive Drugs

Regulatory Control of Potentially Addictive Drugs

Scholar explains why the DEA—not FDA—has power over the classification of potentially addictive substances.